Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update
16 août 2021 07h00 HE
|
Teligent, Inc.
–Update on FDA Inspection of Buena Facility–Assessing New Growth Opportunities in Injectables–Conference Call to Be Held on August 16, 2021 at 8:30 am Eastern Standard Time –Dial in: (877) 407-0792...
Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021
11 août 2021 16h05 HE
|
Teligent, Inc.
BUENA, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a...
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
30 juin 2021 11h00 HE
|
Teligent, Inc.
Scheduled to Reconvene on July 21, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 30, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty...
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
18 juin 2021 11h00 HE
|
Teligent, Inc.
Scheduled to Reconvene on June 30, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 18, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty...
Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update
25 mai 2021 07h00 HE
|
Teligent, Inc.
–Continued Remediation Progress Being Made–Reiterating Prior Guidance of Informing FDA on Inspection Readiness During 3Q2021–Conference Call to Be Held on May 25, 2021 at 4:30 pm Eastern Standard...
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020
21 mai 2021 16h30 HE
|
Teligent, Inc.
BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a...
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update
03 mai 2021 18h45 HE
|
Teligent, Inc.
– Significantly strengthened balance sheet and cash position – Continued FDA Warning Letter remediation efforts – Anticipate informing FDA on inspection readiness during 3Q2021 – Conference Call to...
Teligent Announces Hiring of Chief Financial Officer
15 avr. 2021 07h30 HE
|
Teligent, Inc.
BUENA, N.J., April 15, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced the hiring...
Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule
22 janv. 2021 09h00 HE
|
Teligent, Inc.
BUENA, N.J., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice...
Teligent, Inc. Announces Third Quarter 2020 Results
31 déc. 2020 15h21 HE
|
Teligent, Inc.
BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter...